WEBINAR

Profiling the Impact of Probiotic Supplementation for Low Bone Mineral Density

Osteoporosis is a common disease primarily affecting older populations, characterized by reduced bone mineral density (BMD) which leads to increased susceptibility of fragility fractures. Previous studies have identified that gut microbiota is a key regulator of bone metabolism. In this case study, Metabolon’s Field Metabolomics Specialist, Natasa Giallourou discusses how, with Metabolon’s support, the authors of this study showed that supplementation of L. reuteri could reduce bone loss by approximately 50% in older women with low BMD.

Read the full case study here:

Case Study: The Impact of Probiotic Supplementation on Low Bone Mineral Density (BMD)

Evaluating the Effect of a Novel Alzheimer's Disease (AD) Drug

WATCH THE WEBINAR

Contact Us

Talk with an expert

Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1711

+1 (919) 572-1721

International Headquarters

Metabolon GmbH

Zeppelinstraße 3
85399 Hallbergmoos
Germany